| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2020 ( Subtotal = -$3,048,851 ) |
| | 2020 | 2019 | AARON DIAMOND AIDS RESEARCH CENTER FOR THE CITY OF NEW YORK, INC., THE | 455 FIRST AVE 7TH FL | NEW YORK | NY | 10016-9102 | NEW YORK | USA | R01AI122953 | Novel HIV-1 Env trimer probes for efficient isolation of broadly neutralizing antibodies | 002 | 4 | NIH | 5/12/2020 | $0 |
| | 2020 | 2019 | AARON DIAMOND AIDS RESEARCH CENTER FOR THE CITY OF NEW YORK, INC., THE | 455 FIRST AVE 7TH FL | NEW YORK | NY | 10016-9102 | NEW YORK | USA | R01MH119884 | Yunnan-ADARC HIV Prevention Program: Developing and Testing a Model to Implement and Sustain PrEP Delivery in China. | 000 | 1 | NIH | 1/24/2020 | -$2,302 |
| | 2020 | 2019 | AARON DIAMOND AIDS RESEARCH CENTER FOR THE CITY OF NEW YORK, INC., THE | 455 FIRST AVE 7TH FL | NEW YORK | NY | 10016-9102 | NEW YORK | USA | R01AI100720 | Evolutionary potential of HIV-1 capsid: mechanisms and consequences | 002 | 8 | NIH | 5/12/2020 | $0 |
| | 2020 | 2019 | AARON DIAMOND AIDS RESEARCH CENTER FOR THE CITY OF NEW YORK, INC., THE | 455 FIRST AVE 7TH FL | NEW YORK | NY | 10016-9102 | NEW YORK | USA | R01AI100720 | Evolutionary potential of HIV-1 capsid: mechanisms and consequences | 000 | 8 | NIH | 1/9/2020 | -$477,989 |
| | 2020 | 2019 | AARON DIAMOND AIDS RESEARCH CENTER FOR THE CITY OF NEW YORK, INC., THE | 455 FIRST AVE 7TH FL | NEW YORK | NY | 10016-9102 | NEW YORK | USA | R01AI129802 | Bispecific and Trispecific Anti-Env Antibodies for Eliminating HIV Reservoir Cells | 000 | 3 | NIH | 1/17/2020 | -$449,653 |
| | 2020 | 2019 | AARON DIAMOND AIDS RESEARCH CENTER FOR THE CITY OF NEW YORK, INC., THE | 455 FIRST AVE 7TH FL | NEW YORK | NY | 10016-9102 | NEW YORK | USA | R01AI129802 | Bispecific and Trispecific Anti-Env Antibodies for Eliminating HIV Reservoir Cells | 002 | 3 | NIH | 5/12/2020 | $0 |
| | 2020 | 2019 | AARON DIAMOND AIDS RESEARCH CENTER FOR THE CITY OF NEW YORK, INC., THE | 455 FIRST AVE 7TH FL | NEW YORK | NY | 10016-9102 | NEW YORK | USA | R01AI134328 | Bispecific-Antibody-Drug Conjugates for Selective Targeting and Activation of the HIV Latent Reservoir | 000 | 3 | NIH | 1/16/2020 | -$251,448 |
| | 2020 | 2019 | AARON DIAMOND AIDS RESEARCH CENTER FOR THE CITY OF NEW YORK, INC., THE | 455 FIRST AVE 7TH FL | NEW YORK | NY | 10016-9102 | NEW YORK | USA | R01AI134328 | Bispecific-Antibody-Drug Conjugates for Selective Targeting and Activation of the HIV Latent Reservoir | 002 | 3 | NIH | 5/12/2020 | $0 |
| | 2020 | 2019 | AARON DIAMOND AIDS RESEARCH CENTER FOR THE CITY OF NEW YORK, INC., THE | 455 FIRST AVE 7TH FL | NEW YORK | NY | 10016-9102 | NEW YORK | USA | R01AI145570 | Single-cell analysis of HIV-1 production and transmission | 000 | 1 | NIH | 1/20/2020 | -$315,005 |
| | 2020 | 2019 | AARON DIAMOND AIDS RESEARCH CENTER FOR THE CITY OF NEW YORK, INC., THE | 455 FIRST AVE 7TH FL | NEW YORK | NY | 10016-9102 | NEW YORK | USA | R01AI145570 | Single-cell analysis of HIV-1 production and transmission | 003 | 1 | NIH | 5/12/2020 | $0 |
| | 2020 | 2019 | AARON DIAMOND AIDS RESEARCH CENTER FOR THE CITY OF NEW YORK, INC., THE | 455 FIRST AVE 7TH FL | NEW YORK | NY | 10016-9102 | NEW YORK | USA | R01AI145645 | Quantifying Effector Functions of Anti-HIV IgG1 Antibodies In Vivo. | 000 | 1 | NIH | 1/16/2020 | -$690,667 |
| | 2020 | 2019 | AARON DIAMOND AIDS RESEARCH CENTER FOR THE CITY OF NEW YORK, INC., THE | 455 FIRST AVE 7TH FL | NEW YORK | NY | 10016-9102 | NEW YORK | USA | R01AI145645 | Quantifying Effector Functions of Anti-HIV IgG1 Antibodies In Vivo. | 003 | 1 | NIH | 5/12/2020 | $0 |
| | 2020 | 2019 | AARON DIAMOND AIDS RESEARCH CENTER FOR THE CITY OF NEW YORK, INC., THE | 455 FIRST AVE 7TH FL | NEW YORK | NY | 10016-9102 | NEW YORK | USA | R01AI100720 | Evolutionary potential of HIV-1 capsid: mechanisms and consequences | 001 | 9 | NIH | 1/9/2020 | $400,677 |
| | 2020 | 2019 | AARON DIAMOND AIDS RESEARCH CENTER FOR THE CITY OF NEW YORK, INC., THE | 455 FIRST AVE 7TH FL | NEW YORK | NY | 10016-9102 | NEW YORK | USA | R01AI122953 | Novel HIV-1 Env trimer probes for efficient isolation of broadly neutralizing antibodies | 000 | 4 | NIH | 1/21/2020 | -$497,159 |
| | 2020 | 2019 | AARON DIAMOND AIDS RESEARCH CENTER FOR THE CITY OF NEW YORK, INC., THE | 455 FIRST AVE 7TH FL | NEW YORK | NY | 10016-9102 | NEW YORK | USA | R01MH119884 | Yunnan-ADARC HIV Prevention Program: Developing and Testing a Model to Implement and Sustain PrEP Delivery in China. | 000 | 1 | NIH | 1/24/2020 | -$765,305 |
| | 2020 | 2018 | AARON DIAMOND AIDS RESEARCH CENTER FOR THE CITY OF NEW YORK, INC., THE | 455 FIRST AVE 7TH FL | NEW YORK | NY | 10016-9102 | NEW YORK | USA | R01AI114380 | Deep Sequencing to Identify B-Cell Precursors of HIV-1 Neutralizing Antibodies | 000 | 5 | NIH | 4/4/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $5,186,269 ) |
| | 2019 | 2019 | AARON DIAMOND AIDS RESEARCH CENTER FOR THE CITY OF NEW YORK, INC., THE | 455 FIRST AVE 7TH FL | NEW YORK | NY | 10016-9102 | NEW YORK | USA | R01AI134328 | Bispecific-Antibody-Drug Conjugates for Selective Targeting and Activation of the HIV Latent Reservoir | 000 | 3 | NIH | 6/24/2019 | $606,100 |
| | 2019 | 2019 | AARON DIAMOND AIDS RESEARCH CENTER FOR THE CITY OF NEW YORK, INC., THE | 455 FIRST AVE 7TH FL | NEW YORK | NY | 10016-9102 | NEW YORK | USA | R01AI145570 | Single-cell analysis of HIV-1 production and transmission | 000 | 1 | NIH | 4/4/2019 | $655,240 |
| | 2019 | 2019 | AARON DIAMOND AIDS RESEARCH CENTER FOR THE CITY OF NEW YORK, INC., THE | 455 FIRST AVE 7TH FL | NEW YORK | NY | 10016-9102 | NEW YORK | USA | R01MH119884 | Yunnan-ADARC HIV Prevention Program: Developing and Testing a Model to Implement and Sustain PrEP Delivery in China. | 000 | 1 | NIH | 6/19/2019 | $887,313 |
| | 2019 | 2019 | AARON DIAMOND AIDS RESEARCH CENTER FOR THE CITY OF NEW YORK, INC., THE | 455 FIRST AVE 7TH FL | NEW YORK | NY | 10016-9102 | NEW YORK | USA | R01MH119884 | Yunnan-ADARC HIV Prevention Program: Developing and Testing a Model to Implement and Sustain PrEP Delivery in China. | 000 | 1 | NIH | 6/19/2019 | $2,302 |
| | 2019 | 2019 | AARON DIAMOND AIDS RESEARCH CENTER FOR THE CITY OF NEW YORK, INC., THE | 455 FIRST AVE 7TH FL | NEW YORK | NY | 10016-9102 | NEW YORK | USA | R01AI100720 | Evolutionary potential of HIV-1 capsid: mechanisms and consequences | 000 | 8 | NIH | 7/17/2019 | $554,089 |
| | 2019 | 2019 | AARON DIAMOND AIDS RESEARCH CENTER FOR THE CITY OF NEW YORK, INC., THE | 455 FIRST AVE 7TH FL | NEW YORK | NY | 10016-9102 | NEW YORK | USA | R01AI145645 | Quantifying Effector Functions of Anti-HIV IgG1 Antibodies In Vivo. | 000 | 1 | NIH | 8/30/2019 | $963,733 |
| | 2019 | 2019 | AARON DIAMOND AIDS RESEARCH CENTER FOR THE CITY OF NEW YORK, INC., THE | 455 FIRST AVE 7TH FL | NEW YORK | NY | 10016-9102 | NEW YORK | USA | R01AI122953 | Novel HIV-1 Env trimer probes for efficient isolation of broadly neutralizing antibodies | 000 | 4 | NIH | 7/26/2019 | $630,183 |
| | 2019 | 2019 | AARON DIAMOND AIDS RESEARCH CENTER FOR THE CITY OF NEW YORK, INC., THE | 455 FIRST AVE 7TH FL | NEW YORK | NY | 10016-9102 | NEW YORK | USA | R01AI129802 | Bispecific and Trispecific Anti-Env Antibodies for Eliminating HIV Reservoir Cells | 000 | 3 | NIH | 7/2/2019 | $893,315 |
| | 2019 | 2017 | AARON DIAMOND AIDS RESEARCH CENTER FOR THE CITY OF NEW YORK, INC., THE | 455 FIRST AVE 7TH FL | NEW YORK | NY | 10016-9102 | NEW YORK | USA | R56AI125128 | Single-Cell Analysis of HIV Replication | 000 | 1 | NIH | 9/26/2019 | $0 |
| | 2019 | 2016 | AARON DIAMOND AIDS RESEARCH CENTER FOR THE CITY OF NEW YORK, INC., THE | 455 FIRST AVE 7TH FL | NEW YORK | NY | 10016-9102 | NEW YORK | USA | F32AI116263 | Mechanism of lentiviral inhibition by Mx2 | 000 | 2 | NIH | 9/16/2019 | -$6,006 |
|
| Issue Date FY: 2018 ( Subtotal = $3,216,062 ) |
| | 2018 | 2018 | AARON DIAMOND AIDS RESEARCH CENTER FOR THE CITY OF NEW YORK, INC., THE | 455 FIRST AVE 7TH FL | NEW YORK | NY | 10016-9102 | NEW YORK | USA | R01AI100720 | Evolutionary potential of HIV-1 capsid: mechanisms and consequences | 000 | 7 | NIH | 7/18/2018 | $590,564 |
| | 2018 | 2018 | AARON DIAMOND AIDS RESEARCH CENTER FOR THE CITY OF NEW YORK, INC., THE | 455 FIRST AVE 7TH FL | NEW YORK | NY | 10016-9102 | NEW YORK | USA | R01AI134328 | Bispecific-Antibody-Drug Conjugates for Selective Targeting and Activation of the HIV Latent Reservoir | 000 | 2 | NIH | 6/26/2018 | $596,205 |
| | 2018 | 2018 | AARON DIAMOND AIDS RESEARCH CENTER FOR THE CITY OF NEW YORK, INC., THE | 455 FIRST AVE 7TH FL | NEW YORK | NY | 10016-9102 | NEW YORK | USA | R01AI129802 | Bispecific and Trispecific Anti-Env Antibodies for Eliminating HIV Reservoir Cells | 000 | 2 | NIH | 6/29/2018 | $910,463 |
| | 2018 | 2018 | AARON DIAMOND AIDS RESEARCH CENTER FOR THE CITY OF NEW YORK, INC., THE | 455 FIRST AVE 7TH FL | NEW YORK | NY | 10016-9102 | NEW YORK | USA | R01AI122953 | Novel HIV-1 Env trimer probes for efficient isolation of broadly neutralizing antibodies | 000 | 3 | NIH | 6/27/2018 | $631,830 |
| | 2018 | 2018 | AARON DIAMOND AIDS RESEARCH CENTER FOR THE CITY OF NEW YORK, INC., THE | 455 FIRST AVE 7TH FL | NEW YORK | NY | 10016-9102 | NEW YORK | USA | R01AI114380 | Deep Sequencing to Identify B-Cell Precursors of HIV-1 Neutralizing Antibodies | 000 | 5 | NIH | 6/22/2018 | $487,000 |
| | 2018 | 2017 | AARON DIAMOND AIDS RESEARCH CENTER FOR THE CITY OF NEW YORK, INC., THE | 455 FIRST AVE 7TH FL | NEW YORK | NY | 10016-9102 | NEW YORK | USA | R01AI102891 | Mechanisms of induction of protective anti-malarial CD8+ T Cells | 000 | 4 | NIH | 3/21/2018 | $0 |
| | 2018 | 2016 | AARON DIAMOND AIDS RESEARCH CENTER FOR THE CITY OF NEW YORK, INC., THE | 455 FIRST AVE 7TH FL | NEW YORK | NY | 10016-9102 | NEW YORK | USA | R01DA033777 | Correlates and Consequences of Increased Immune Activation in HIV + and - IDUs | 000 | 5 | NIH | 5/24/2018 | $0 |
| | 2018 | 2016 | AARON DIAMOND AIDS RESEARCH CENTER FOR THE CITY OF NEW YORK, INC., THE | 455 FIRST AVE 7TH FL | NEW YORK | NY | 10016-9102 | NEW YORK | USA | R01AI070258 | CD1d/NKT-binding glycolipids in enhancing the immunogenicity of a malaria vaccine | 000 | 6 | NIH | 10/31/2017 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $3,312,937 ) (Continued on the next page) |
| | 2017 | 2017 | AARON DIAMOND AIDS RESEARCH CENTER FOR THE CITY OF NEW YORK, INC., THE | 455 FIRST AVE 7TH FL | NEW YORK | NY | 10016-9102 | NEW YORK | USA | R01AI129802 | Bispecific and Trispecific Anti-Env Antibodies for Eliminating HIV Reservoir Cells | 001 | 1 | NIH | 7/6/2017 | -$13,838 |
| | 2017 | 2017 | AARON DIAMOND AIDS RESEARCH CENTER FOR THE CITY OF NEW YORK, INC., THE | 455 FIRST AVE 7TH FL | NEW YORK | NY | 10016-9102 | NEW YORK | USA | R01AI134328 | Bispecific-Antibody-Drug Conjugates for Selective Targeting and Activation of the HIV Latent Reservoir | 000 | 1 | NIH | 7/25/2017 | $595,153 |
| | 2017 | 2017 | AARON DIAMOND AIDS RESEARCH CENTER FOR THE CITY OF NEW YORK, INC., THE | 455 FIRST AVE 7TH FL | NEW YORK | NY | 10016-9102 | NEW YORK | USA | R01AI122953 | Novel HIV-1 Env trimer probes for efficient isolation of broadly neutralizing antibodies | 000 | 2 | NIH | 7/20/2017 | $633,429 |
| | 2017 | 2017 | AARON DIAMOND AIDS RESEARCH CENTER FOR THE CITY OF NEW YORK, INC., THE | 455 FIRST AVE 7TH FL | NEW YORK | NY | 10016-9102 | NEW YORK | USA | R01AI129802 | Bispecific and Trispecific Anti-Env Antibodies for Eliminating HIV Reservoir Cells | 000 | 1 | NIH | 7/5/2017 | $944,284 |
| | 2017 | 2017 | AARON DIAMOND AIDS RESEARCH CENTER FOR THE CITY OF NEW YORK, INC., THE | 455 FIRST AVE 7TH FL | NEW YORK | NY | 10016-9102 | NEW YORK | USA | R01AI100720 | Diverse Functions of HIV-1 Capsid During Postentry Events | 001 | 6 | NIH | 8/15/2017 | $605,878 |
| | 2017 | 2017 | AARON DIAMOND AIDS RESEARCH CENTER FOR THE CITY OF NEW YORK, INC., THE | 455 FIRST AVE 7TH FL | NEW YORK | NY | 10016-9102 | NEW YORK | USA | R01AI114380 | Deep Sequencing to Identify B-Cell Precursors of HIV-1 Neutralizing Antibodies | 000 | 4 | NIH | 6/14/2017 | $487,000 |
| | 2017 | 2017 | AARON DIAMOND AIDS RESEARCH CENTER FOR THE CITY OF NEW YORK, INC., THE | 455 FIRST AVE 7TH FL | NEW YORK | NY | 10016-9102 | NEW YORK | USA | R56AI125128 | Single-Cell Analysis of HIV Replication | 000 | 1 | NIH | 7/13/2017 | $494,750 |
| | 2017 | 2017 | AARON DIAMOND AIDS RESEARCH CENTER FOR THE CITY OF NEW YORK, INC, THE | 455 FIRST AVE 7TH FL | NEW YORK | NY | 10016-9102 | NEW YORK | USA | R01AI102891 | Mechanisms of induction of protective anti-malarial CD8+ T Cells | 000 | 4 | NIH | 2/17/2017 | $350,000 |
| | 2017 | 2016 | AARON DIAMOND AIDS RESEARCH CENTER FOR THE CITY OF NEW YORK, INC, THE | 455 FIRST AVE 7TH FL | NEW YORK | NY | 10016-9102 | NEW YORK | USA | R01AI078788 | Overcoming Host Restriction Factors to Develop Better Animal Models for HIV/AIDS | 004 | 9 | NIH | 3/6/2017 | $90 |
| | 2017 | 2016 | AARON DIAMOND AIDS RESEARCH CENTER FOR THE CITY OF NEW YORK, INC, THE | 455 FIRST AVE 7TH FL | NEW YORK | NY | 10016-9102 | NEW YORK | USA | R01AI050111 | RNA Protein interactions in HIV-1 replication | 000 | 15 | NIH | 2/9/2017 | -$228,530 |
| | 2017 | 2016 | AARON DIAMOND AIDS RESEARCH CENTER FOR THE CITY OF NEW YORK, INC., THE | 455 FIRST AVE 7TH FL | NEW YORK | NY | 10016-9102 | NEW YORK | USA | R01AI100720 | Diverse Functions of HIV-1 Capsid During Postentry Events | 002 | 5 | NIH | 9/26/2017 | $0 |
| | 2017 | 2016 | AARON DIAMOND AIDS RESEARCH CENTER FOR THE CITY OF NEW YORK, INC., THE | 455 FIRST AVE 7TH FL | NEW YORK | NY | 10016-9102 | NEW YORK | USA | R01AI100720 | Diverse Functions of HIV-1 Capsid During Postentry Events | 000 | 5 | NIH | 8/14/2017 | $0 |
|
